Evidence map›Paper›PMID 42780579›Full record

ReviewFrontiers in pharmacology2026

Research progress on protein lactylation in female reproductive disease: molecular mechanisms, functions, and therapeutic implications.

Xiaoyang Shen, Yan Chen, Hongxia Deng, Nannan Zhang, Liangzhi Xu

Abstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xiaoyang Shen *Reproductive Endocrinology and Regulation Laboratory, West China Second University Hospital, Sichuan University, Chengdu, China.
Yan Chen *Reproductive Endocrinology and Regulation Laboratory, West China Second University Hospital, Sichuan University, Chengdu, China.
Hongxia DengReproductive Endocrinology and Regulation Laboratory, West China Second University Hospital, Sichuan University, Chengdu, China.
Nannan ZhangKey Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, China.
Liangzhi XuReproductive Endocrinology and Regulation Laboratory, West China Second University Hospital, Sichuan University, Chengdu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Female reproductive health depends on precisely coordinated metabolic, hormonal, immune, and epigenetic networks. Lactylation is a lactate-derived lysine post-translational modification that provides a direct mechanism by which glycolytic metabolism influences chromatin activity and protein function. Lactylation exerts diverse biological effects across multiple systems, including the cardiovascular, musculoskeletal, nervous, and urinary systems. Although individual studies have indicated that lactylation participates in key reproductive processes and contributes to various female reproductive disorders, the mechanisms connecting lactylation with female reproductive health and disease have not been systematically reviewed. Thus, we provide an integrated overview of lactylation-associated cellular mechanisms and the research progress in female reproductive health and disease. This review examines the molecular mechanisms of lactylation and its interactions with other post-translational modifications. We further summarize the physiological and pathological functions of lactylation in the female reproductive system, with particular emphasis on its context-dependent and double-edged role. We also outline emerging therapeutic strategies targeting lactate production, transport, lactylation enzymes, specific lactylation sites, together with clinical trials, while emphasizing key challenges associated with tissue specificity, reproductive safety, and precise modulation. This review highlights lactylation as a metabolic-epigenetic regulator and a potential therapeutic target for precision management of female reproductive diseases.

Indexed as

epigenetic regulationfemale reproductive diseasesgynecological tumorslactatelactylationpost-translational modificationtherapeutic target

Identifiers

PMID42780579
PMCPMC13598466

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.